Cargando…
Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
BACKGROUND: Crohn's disease (CD) causes a range of digestive symptoms including recurrent diarrhea, abdominalgia, and flatulence, and severely impacts the quality of life of patients. Infliximab, a monoclonal antibody against tumor necrosis factor alpha, has recently been promoted as a therapeu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040059/ https://www.ncbi.nlm.nih.gov/pubmed/33889281 http://dx.doi.org/10.4251/wjgo.v13.i4.305 |